Pamrevlumab
Pamrevlumab (INN; development code FG-3019) is a humanized monoclonal antibody designed for the treatment of idiopathic pulmonary fibrosis and pancreatic cancer.
≈ 1 min read
Pamrevlumab. encyclopegia.org, snapshot enwiki-001315055160. /a/pamrevlumab
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Pamrevlumab (INN; development code FG-3019) is a humanized monoclonal antibody designed for the treatment of idiopathic pulmonary fibrosis and pancreatic cancer. It binds to the connective tissue growth factor (CTGF) protein. This drug was developed by FibroGen.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1315055160 under CC BY-SA 4.0; modifications have been made.